Legal NewsRoom
Menu
Menu
LEGAL NEWS
HOT TOPICS
LexisNexis® Legal Newsroom
ACA and Healthcare Reform
Antitrust and Unfair Competition
Banking and Finance
Bankruptcy
California
Climate Change
Constitutional Law and Civil Rights
Consumer Protection & Privacy
Contracts and Commercial Law
Corporate
Criminal Law and Procedure
Energy
Environmental
Estate and Elder Law
Family Law
Financial Fraud Law
Florida
Fracking and Alternative Energy
Health Care
Hot Topics
Hurricane Sandy
Illinois
Immigration Law
Immigration Reform
Insurance Law
Intellectual Property
International Law
International Trade
Labor and Employment Law
Law360
Legal Business
Lexis® Hub
Litigation
Mealeys
Media and Entertainment
Mergers and Acquisitions
New Jersey
New York
Pennsylvania
Public Contracts
Public media
Public Policy
Real Estate Law
Securities
Sports Law
Tax Law
Technology
Texas
Top Emerging Trends
Torts
Virtual Currency
Workers' Compensation
NEWS & INSIGHT
Blogs and Newsletters
BIZ Blog
Blog Mosaic
Business of Law Blog
Corporate Law Advisory
Legal Content Insider
LexTalk
State Net
®
Capitol Journal
News & Trending Topics
Law360
Legal Insights & Trends
Lexis Practice Advisor Journal
Professional Communities
Business Insight Solutions – Partner Portal
Corporate InfoPro (Corporate Information Professionals)
InfoPro (Legal Information Professionals)
LexisNexis
®
for Developers
Litigators Verdict & Settlement Exchange
VISIT LEXISNEXIS LEGAL & PROFESSIONAL
Search
Search
Please enter a Keyword
This should not be used for legal research but instead can be used to find solutions that will help you do legal research.
Sign In
Browse By Tags
Barr Pharmaceuticals Inc.
breast cancer
cancer drug
drug maker
Fosamax
Hospira Inc.
In Re: Fosamax [Alendronate Sodium] Products Liability Litigation [No. II]
lawsuit
Litigation
MDL
Merck Sharp & Dohme Corp.
multidistrict litigation
Mylan Pharmaceuticals Inc.
osteoporosis drug
Patent
preemption
prostate cancer
Sanofi-Aventis
Sun Pharmaceutical Industries Inc.
Taxotere
Teva Pharmaceuticals USA
Third Circuit
torts
U.S. Supreme Court
Watson Pharmaceuticals Inc.
Tom Moylan
over 8 years ago
Litigation
Litigation Blog
3rd Circuit Says Design Defect Claims For Generic Fosamax Are Preempted
PHILADELPHIA — (Mealey’s) Strict liability design defect claims involving generic versions of the osteoporosis drug Fosamax are preempted by federal law despite plaintiffs’ attempts to narrow U.S. Supreme Court case law, a panel of the...
LexisNexis Litigation Resource Community Staff
over 12 years ago
Litigation
News Headlines
Sanofi Loses Cancer Drug Patent Fight In Delaware
WILMINGTON, Del. - (AP) A federal judge in Delaware has ruled against French drug maker Sanofi-Aventis SA in a patent dispute involving its cancer drug Taxotere. Full version available to lexis.com subscribers .